Home » Topics » BioWorld Science

BioWorld Science
RSS

CV-6-168, a dUTPase inhibitor that sensitizes multiple cancer types to TS-targeted therapies

Nov. 23, 2018

Weekly and monthly Buvidal approved in Europe for opioid dependence

Nov. 23, 2018

New anti-inflammation target has similarities, and differences, to PARP

Nov. 23, 2018

New path to RAS activation discovered

Nov. 23, 2018

HitGen and Biogen form drug discovery research collaboration

Nov. 22, 2018

Phase I results demonstrate encouraging efficacy for D2C7-IT in malignant glioma

Nov. 22, 2018

Arcus presents novel small-molecule CD73 inhibitors for orally bioavailable cancer therapy

Nov. 22, 2018

REALIST study explores use of mesenchymal stem cells to treat ARDS

Nov. 22, 2018

New phase II/III study in Hong Kong investigates JCM-16021 for diarrhea-predominant IBS

Nov. 22, 2018

GlaxoSmithKline begins first-in-human study of GSK-3368715 in solid tumors and DLBCL

Nov. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...